[1]
“Synergism of EGFR and c-Met pathways, cross-talk and inhibition, in non-small cell lung cancer”, JOC, vol. 7, no. 1, Sep. 2008, Accessed: Apr. 30, 2026. [Online]. Available: https://carcinogenesis.com/index.php/JOC/article/view/204